中国卒中杂志2018，Vol.13Issue(5)：483-488,6.DOI:10.3969/j.issn.1673-5765.2018.05.014
高危非致残性缺血性脑血管事件的循证医学治疗
Evidence-based Treatment of High Risk Non-Disabling Ischemic Cerebrovascular Events
马琳 1陈玮琪 2荆京 1王拥军 2王伊龙1
作者信息
- 1. 100050 北京 首都医科大学附属北京天坛医院神经病学中心
- 2. 国家神经系统疾病临床医学研究中心
- 折叠
摘要
Abstract
The incidence and recurrence rate of high risk of disabling ischemic cerebrovascular events (HR-NICE) are high. The guidelines of both home and abroad suggest that the early comprehensive evaluation, intervention and establishing NICE management system will obtain great benefit. Several studies have revealed the efficacy and safety of antiplatelet medication, and choosing anticoagulation or thrombolysis treatment according to different cause, which may improve the prognosis. This article briefly reviews the evidence-based medicine in management of HR-NICE.关键词
高危非致残性脑血管事件/综合管理系统/抗栓/二级预防/溶栓Key words
High risk non-disabling ischemic cerebrovascular events/Comprehensive management system/Antithrombotic therapy/Secondary prevention/Thrombolysis引用本文复制引用
马琳,陈玮琪,荆京,王拥军,王伊龙..高危非致残性缺血性脑血管事件的循证医学治疗[J].中国卒中杂志,2018,13(5):483-488,6.
